Skip to main content
. 2023 Apr 24;2023:8832242. doi: 10.1155/2023/8832242

Table 2.

Changes in clinical parameters during the patient follow-up (2019–2022).

Main parameters Before benralizumab (2019) After benralizumab (to date)
Eosinophils (cell/μL) 290 0
Prednisolone (mg) 20 5
ACT (points) 19 23
CARAT (points) 22 23
Mini-AQLQ (points) 3 4.7